Rahul Jandial, M.D., Ph.D.: Pediatric Neurosurgery Humanitarian Missions

March 13, 2018 | Denise Heady

Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.

Continue Reading

With New CAR T Approach, City of Hope CEACAM Research Comes Full Circle

February 9, 2018 | Jyoti Madhusoodanan

More than 50 years after its discovery, CEA remains one of the most widely used clinical markers of cancer. As the diverse roles of CEA and its family members, known as CEA-related cell adhesion molecules (CEACAMs), have grown clearer, researchers at City of Hope are working on a new wave of clinical tools and therapies.

On World Cancer Day: Five ways City of Hope physicians, researchers are finding new ways to treat cancer

February 2, 2018 | Denise Heady

Sunday, February 4, is World Cancer Day. Here, we’ve spotlighted how teams at City of Hope are improving the care and treatment of patients diagnosed with cancer everywhere.

Meet Our CAR T Team: Christine Brown, Ph.D.

January 26, 2018 | Abe Rosenberg

Christine Brown, Ph.D., co-leads the T Cell Therapeutics Research Laboratory, along with Stephen J. Forman, M.D., which to date has treated more than 100 patients in seven clinical trials, with aggressive goals of opening four new clinical studies within the year.

Meet the CAR T Team: Xiuli Wang, Ph.D.

January 4, 2018 | Maxine Nunes

Xiuli Wang, Ph.D., is at the forefront of one of the most exciting breakthroughs in cancer treatment, chimeric antigen receptor (CAR) T cell therapy.

City of Hope Physicians Announce New CAR T Breakthroughs at Annual ASH Meeting

December 14, 2017 | Letisia Marquez

New blood cancer breakthroughs – including several involving CAR T cell therapy – were announced by City of Hope physicians at the American Society of Hematology (ASH) annual meeting in Atlanta.

MEET OUR DOCTORS: Behnam Badie on why ‘being a neurosurgeon is not enough’

November 2, 2017 | Denise Heady

Driven in part by the plight of his patients and his father, chief of neurosurgery Behnam Badie, M.D., spends nearly as much time in the laboratory as he does in the operating room. He wants to help not just today's patients, but tomorrow's. 

Brain tumors and cancer: what you need to know

November 1, 2017 | Denise Heady

Say the words “brain tumor” and most people will likely think of cancer. But there’s reason for optimism - recent advances in screening and treatment, such as CAR T cell therapy, mean patient outcomes and quality of life are continuing to improve.

City of Hope to Provide First FDA-approved CAR T Cell Therapy for Some Types of Lymphoma

October 18, 2017 | City of Hope

City of Hope will be the one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. Food and Drug Administration (FDA) announced today is the first approved CAR T therapy for adult patients who have not responded to or who have relapsed after at least two other kinds of treatment.

Load More
/* */